Yuki Katoh

9PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
Serum Palmitoleic Acid and Arachidonic Acid as a Noninvasive Screening Tool for Endometrial Cancer.

|May 11, 2026
Establishment and genomic characterization of patient-derived organoids from gastric-type cervical adenocarcinoma.

|Aug 23, 2025
Hexanoic Acid Intake Enhances Anti-Tumor Immune Responses in Colorectal Cancer by Reducing the Immunosuppressive Function of Tregs.

Daichi Seta, Kenta Nagahori, Yuki Katoh

|Sep 06, 2024
Serum levels of stearic and dihomo-γ-linolenic acids can be used to diagnose cervical cancer and cervical intraepithelial neoplasia.

Yuki Katoh, Akiko Kubo, Nobuki Hayashi

|Jun 07, 2024
FADS2 confers SCD1 inhibition resistance to cancer cells by modulating the ER stress response.

Toshikatsu Ikeda, Yuki Katoh, Hirotsugu Hino

|Oct 25, 2023
SCD1 inhibition enhances the effector functions of CD8+ T cells via ACAT1-dependent reduction of esterified cholesterol.

Toshihiro Sugi, Yuki Katoh, Toshikatsu Ikeda

Pageof 2

Frequent Collaborators

4 joint publications

Masaki Sugawara

3 joint publications

Takashi Iwata

2 joint publications

Hiroshi Nishio

2 joint publications

Akiko Kubo